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ABSTRACT: Vitamin D plays a key role in the maintenance of
calcium/phosphate homeostasis and elicits biological effects that are
relevant to immune function and metabolism. It is predominantly
formed through UV exposure in the skin by conversion of 7-
dehydrocholsterol (vitamin D3). The clinical biomarker, 25-
hydroxyvitamin D (25-(OH)-D), is enzymatically generated in the
liver with the active hormone 1,25-dihydroxyvitamin D then formed
under classical endocrine control in the kidney. Vitamin D metabolites
are measured in biomatrices by liquid chromatography−tandem mass
spectrometry (LC−MS/MS). In LC−MS/MS, chemical derivatiza-
tion (CD) approaches have been employed to achieve the desired
limit of quantitation. Recently, matrix-assisted laser desorption/
ionization (MALDI) has also been reported as an alternative method.
However, these quantitative approaches do not offer any spatial
information. Mass spectrometry imaging (MSI) has been proven to be a powerful tool to image the spatial distribution of molecules
from the surface of biological tissue sections. On-tissue chemical derivatization (OTCD) enables MSI to image molecules with poor
ionization efficiently. In this technical report, several derivatization reagents and OTCD methods were evaluated using different MSI
ionization techniques. Here, a method for detection and spatial distribution of vitamin D metabolites in murine kidney tissue
sections using an OTCD−MALDI−MSI platform is presented. Moreover, the suitability of using the Bruker ImagePrep for OTCD-
based platforms has been demonstrated. Importantly, this method opens the door for expanding the range of other poor ionizable
molecules that can be studied by OTCD−MSI by adapting existing CD methods.
■ INTRODUCTION
Vitamin D has become a priority area of research worldwide. It
is a vital component for a number of biological processes such
as calcium homeostasis1 and immune function.2 The hormone
is studied not only from the aspect of vitamin D deficiency
against diseases such as rickets or osteoporosis3,4 but also as a
potential treatment of diseases including cancer and mental
disorders.5−8 Vitamin D is mainly formed through UV
exposure to the skin, through conversion of 7-dehydrocholes-
terol to the metabolite vitamin D3 but can also be supplied via
vitamin-D-sourced foods as vitamin D2.
9−11 The precursor is
metabolized in the liver via enzymatic hydroxylation to
produce 25-hydroxyvitamin D (25-(OH)-D), a clinical
biomarker. Further hydroxylation is then carried out in the
kidney, producing the active hormone 1α,25-dihydroxyvitamin
D (1,25-(OH)2-D), known to be the active ligand of the
vitamin D receptor protein and elicits transcriptional
effects.12,13 Vitamin D metabolites are primarily measured in
biomatrices by immunoassays or liquid chromatography−
tandem mass spectrometry (LC−MS/MS).14 Steroidal class
compounds are known to have poor ionization efficiency in
mass spectrometry (MS) because of a lack of ionizable
moieties. To overcome this issue, chemical derivatization
(CD) approaches have been used in LC−MS/MS-based
platforms using both electrospray ionization (ESI) and
atmospheric pressure chemical ionization.15,16 CD is intended
to increase the ionization efficiency by tackling ion suppression
effects and potential isobaric interferences. Recently, it has
been shown that vitamin D metabolites, with the aid of CD,
can be detected and quantified by matrix-assisted laser
desorption/ionization (MALDI).17 These methods are pri-
marily being used to assess levels of vitamin D metabolites in
clinical settings. MS is currently being used to measure vitamin
D metabolites in serum/plasma and tissue homogenate
samples. These quantitative approaches, however, do not
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offer any spatial information. Mass spectrometry imaging
(MSI) enables the ability to gain spatial information of various
molecules with spectra being mapped to individual pixels.
Molecules can be localized and quantified to a host of different
organ/tissue types. On-tissue chemical derivatization (OTCD)
is enabling MSI to push the boundary of poor ionizable
molecules to be imaged within tissues by increasing signal
intensity, shifting m/z values, and overcoming poor ionization
performance. Previous studies have shown the use of several
derivatization reagents in MSI applications. Some examples are
Girard-T reagent targeting steroids18,19 and triamcinolone
acetonide,20 pyrylium salts for primary amine moiety
molecules,21 and 1,1′-thiocarbonyldiimidazole for 3-methox-
ysalicylamine.22 Other OTCD approaches have also been
successfully trialed, such as a high-voltage electrospray
deposition using 2-picolylamine for endogenous fatty acids in
rat brain tissue.23
In this article, several derivatization reagents, deposition
techniques, and reaction conditions were evaluated using
different ionization techniques including MALDI and
desorption electrospray ionization (DESI) to achieve best
ion production yields in MSI analysis of vitamin D metabolites
in murine tissue sections. For the first time, a method for
detection and spatial distribution of vitamin D metabolites
using an OTCD−MALDI−MS platform is presented.
Specifically, endogenous 1,25-(OH)2-D3 and 25-(OH)-D3
were detected within a mouse kidney using Amplifex as the
derivatization reagent and results were confirmed by LC−MS/
MS. The suitability of Bruker’s ImagePrep is also demonstrated
Figure 1. On-tissue spotting experiments by MALDI and DESI MSI platforms using Amplifex as a derivatization reagent. (a) Vitamin D−Amplifex
derivatization reaction scheme and (b) on-tissue spotting experiments. (I) Optical image of control tissue section (II) MALDI−MSI molecular
distribution map of spotted d6-25-(OH)-D3 Amplifex derivative at m/z 738.5435 ± 0.005. (III) DESI−MSI molecular distribution map of spotted
ISTD vitamin D standard Amplifex derivative at m/z 738.5435 ± 0.005; (c) representative zoomed-out single-pixel mass spectrum of d6-25-(OH)-
D3-Amplifex derivative spotted region using (I) DESI-qTOF-MS. (II) MALDI−FTICR−MS both with a mass accuracy of 1.08 ppm against
theoretical monoisotopic mass. Data were normalized to TIC. Spatial resolution was set at 100 μm, with scale bars shown. Signal intensity is
depicted by color on the scale shown. Spectrum was postcalibrated to CHCA cluster matrix ion at +ve m/z 417.0483.
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for an automated and robust method for OTCD−MSI
applications.
■ RESULTS AND DISCUSSION
Reagent Screening and Ionization Assessment (Off-
Tissue). This novel application of OTCD coupled with MSI
permits detection of endogenous vitamin D metabolites within
tissues by generating permanently charged derivatives which
yielded intense signals upon MALDI−Fourier transform ion
cyclotron resonance mass spectrometry (FTICR)−MSI
analysis. The spatial distribution of both 25-(OH)-D3 and
1,25-(OH)2-D3 in mouse kidney was assessed. This technique
has the potential to be applied to other vitamin D metabolites
to investigate vitamin D intracrinology in multiple biological
tissues.
In this article, several LC−MS-based derivatization reagents
were evaluated using the reaction conditions to investigate the
performance in different MSI ionization modes, specifically
MALDI and DESI. These reagents (PTAD, DMEQ-TAD, and
Amplifex (Figure S1) were screened off, and on-tissue with
instrument parameters optimized using a stable isotope of
vitamin D (d6-25-hydroxyvitamin-D3 (d6-25-(OH)-D3)) as an
Figure 2. Molecular distribution of endogenous vitamin D metabolites detected as Amplifex derivatives in a mouse kidney section using the
optimized and automated OTCD−MALDI−MSI platform. (a) Illustration of a kidney section; (b) optical image of mouse kidney; (c) molecular
distribution map of 25-OH-D3-Amplifex derivative (m/z 732.5053 ± 0.005); (d) molecular distribution map of 1,25-(OH)2-D3-Amplifex derivative
(m/z 748.4992 ± 0.005); and (e) representative single-pixel MALDI−FTICR−MS mass spectrum for 25-(OH)-D3-Amplifex derivative with a
mass accuracy of 0.68 ppm against theoretical monoisotopic mass (shown inset). (f) Representative single-pixel MALDI−FTICR−MS mass
spectrum for 1,25-(OH)2-D3-Amplifex derivative with a mass accuracy of 1.20 ppm against theoretical monoisotopic mass (shown inset). (g)
Active metabolite (1-25-(OH)2-D3) confirmation by LC−MS/MS. Data were normalized to TIC. Spatial resolution was analyzed at 100 μm, with
scale bars shown. Signal intensity is depicted by color on the scale shown. Spectrum was postcalibrated to CHCA cluster matrix ion at +ve m/z
417.0483.
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internal standard (ITSD). During off-tissue ionization
evaluation, the derivatized PTAD metabolite displayed no
fingerprint signal across any of the investigated ionization
methods, indicating that PTAD is not suitable for MALDI or
DESI analysis. The Amplifex ISTD derivative was detected
using both MALDI−MS at m/z 738.5437; 0.27 ppm mass
accuracy; 1.8 × 108 signal intensity; and signal/noise (S/N) of
3.1 × 108 (Figure S2b) and DESI−MS at m/z 738.5447; 1.62
ppm mass accuracy; 1.1 × 107 signal intensity; and S/N of 1.7
× 106 (Figure S2c). DMEQ-TAD derivative was also detected
using MALDI−MS at m/z 752.4863; 0.12 ppm mass accuracy;
7.2 × 107 signal intensity; and S/N of 2.2 × 105 (Figure S3b)
and DESI−MS at m/z 752.4843; 2.78 ppm mass accuracy; 2.5
× 105 signal intensity; and S/N of 1342 (Figure S3c). As
expected, Amplifex outperformed DMEQ-TAD in terms of ion
signal production for vitamin D metabolite derivatives in
positive ion mode, primarily because of its positively charged
quaternary amine moiety.
On-Tissue Spotting Assessment, Amplifex Reaction
Conditions, and OTCD Sample Preparation Optimiza-
tion. Based on the off-tissue screening results, Amplifex and
DMEQ-TAD were selected as suitable reagents for an on-
tissue ion suppression assessment. On-tissue ionization
suppression was conducted as described in Supporting
Information Section 1.2 using a control (blank) tissue section
(Figure 1). Amplifex derivative was detected on tissue in
MALDI−MSI [Figure 1c(II)] at m/z 738.5435; 0.01 ppm
mass accuracy; 1.4 × 108 signal intensity; and S/N 1.05 × 106
(Figure 1c). Using DESI−MSI (Figure 1cI), the Amplifex
derivative was detected at m/z 738.5435; 0.01 ppm mass
accuracy, with a signal intensity of 1.24 × 106, and S/N of
4427.
The DMEQ-TAD derivative was also detected by MALDI−
MSI at m/z 752.4848; 2.11 ppm mass accuracy with a signal
intensity of 6.3 × 107; and S/N of 1.2 × 104 (Figure S4) and
DESI−MSI at m/z 752.4730; 1.7 ppm mass accuracy, signal
intensity around 0.8 × 104, and S/N of 340 (Figure S5). On-
tissue Amplifex and DMEQ-TAD VitD derivatives showed
good ionization in both the MALDI and DESI−MSI platforms
with best results achieved using the Amplifex-MALDI−MSI
platform. Analyte diffusion was observed during DESI−MSI,
which may be related to solvent spraying and charging effects
caused by the chemical nature of the derivatization reagent.
Based on the results obtained from on-tissue screening
experiments, MALDI−MSI using Amplifex as a derivatization
reagent was selected as the imaging platform for final reaction
and sample preparation optimization. Off- and on-tissue
reaction parameters were evaluated with an optimal CD
Figure 3. Molecular distribution assessment of endogenous vitamin D metabolites detected as Amplifex derivatives on three adjacent sections of
mouse kidney using the optimized and automated OTCD−MALDI−MSI platform. (a) Illustration of a kidney section. [b(I,II)] Optical images of
adjacent mouse kidney. [c(I,III)] Molecular distribution map of 1-25-(OH)2-D3-Amplifex derivative (m/z 748.5001 ± 0.005). [d(I−III)]
Molecular distribution map of 25-(OH)-D3-Amplifex derivative (m/z 732.5058 ± 0.005). Data were normalized to TIC. Spatial resolution was
analyzed at 100 μm, with scale bars shown. Signal intensity is depicted by the color on the scale shown.
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condition achieved at 1 h at room temperature (RT) for both
off-tissue (Figure S6a) and on-tissue derivatization (Figure
S6b). Regarding reagent deposition and OTCD, two methods
were evaluated for MSI performance in terms of analyte
detection, diffusion, and reproducibility. The Bruker Image-
Prep and a commercial artistic airbrush were assessed. The
airbrush application method was adapted from previous
studies,23 and the Bruker ImagePrep method was adapted
and customized for reagent deposition as described in the
Materials and Methods section “OTCD−MSI Analysis of
Endogenous Vitamin D Metabolite Derivatives in Mouse
Kidney Tissue Sections”. Figure S7 clearly shows that the
automated ImagePrep method outperformed the manual
airbrush. Ion signal intensity was increased in the ImagePrep
MS images, as better S/N ratios (ImagePrep 2800 and airbrush
1200) were obtained than with the airbrush method
(Supporting Information Figure S7d). Moreover, tissue-to-
tissue reproducibility and analyte diffusion were improved by
using the Bruker ImagePrep approach (Figure S7d).
When using manual sample preparation methods, analyst-to-
analyst variations have a negative impact on reproducibility in
MS and particularly with MSI analysis. These parameters in
manual OTCD methods are very difficult to control. On the
contrary, these potential issues are well controlled in the
automated method as both reagent application and CD
reaction can be carried out using the same device. In this
method, several key parameters can be controlled such as
drying, incubation time, and spray frequency. Another
advantage of the automated ImagePrep is that both application
and derivatization reaction are performed under an inert
atmosphere, allowing oxygen-sensitive chemical reactions to be
carried out robustly. However, one disadvantage to mention is
that in the ImagePrep, temperature cannot be controlled and
thus would not be applicable to OTCD reactions that require
controlled temperatures.
Distribution of Endogenous Vitamin D Metabolites in
Mouse Kidney Tissue by OTCD−MALDI−FTICR−MSI. For
the first time, vitamin D metabolites were successfully
detected, and their spatial distribution was assessed in murine
kidney tissue sections using the optimized automated OTCD−
MALDI−MSI platform. Hydroxylation of the precursor 25-
hydroxyvitamin D occurs in the kidney to produce the active
metabolite, 1,25-dihydroxyvitamin D, by the enzyme
CYP27B1.28,29 Therefore, this gives a good rationale for the
selection of the kidney as a target/suitable metabolic tissue to
perform this MSI feasibility study.
As shown in Figure 2, two endogenous vitamin D
metabolites were detected as Amplifex derivatives at m/z
732.5053, corresponding to the 25-(OH)-D3 (Figure 2c) and
m/z 748.4992 for 1,25-(OH)2-D3 (Figure 2d), with a mass
accuracy of 0.68 ppm (Figure 2e) and 1.20 ppm (Figure 2f),
against their theoretical monoisotopic protonated masses,
respectively. To confirm the identification of the active
metabolite 1,25-(OH)2-D3, collision-induced dissociation
(CID) experiments were performed on high signal intensity
region of interests (ROI) within the tissue section. The CID
on the M+ ion at m/z 748.49 showed a main fragment at m/z
689.4493 with a loss of 59 Da corresponding to the
trimethylamine moiety (Figure S8). These results are in
agreement with previous literature reports.17 LC/MS was also
performed to confirm the presence of the active metabolite
(1,25-(OH)2-D3) on the tissue homogenate, giving a
concentration of 132.6 pg/g (Figure 2g).
To study the molecular distribution pattern of vitamin D
metabolites across the mouse kidney, the molecular mapping
of three sections were assessed. As shown in Figure 3, 1,25-
(OH)2-D3 was mainly detected across the cortex gathering
near the renal vein and 25-(OH)-D3 was mainly distributed
across the medulla and inner cortex. However, as shown in
Figure 3, the 25-(OH)-D3 metabolite formation was depth-
dependent, as its normalized signal intensity varies across a
series of adjacent kidney sections (n = 3), with the detected
signal decreasing throughout the tissue. This suggests that 3D
molecular mapping analysis may provide valuable information
regarding metabolism across the entire tissue. Knowing the
tissue distribution of vitamin D metabolites may be key in the
understanding of the synthesis and function of the active
metabolite 1,25-(OH)2-D3 as it has a key role in the calcium
absorption and it is a potent ligand in gene transcription
pathways across various tissues.9,30 Previous studies have
detected the CYP27B1 enzyme by immunohistochemistry in
the proximal tubules of kidney nephrons, located in the cortex
region of the tissue.31 In vivo pharmacokinetics and
pharmacodynamics experiments using stable isotope tracers
in combination with MSI might be able to expand the
knowledge of vitamin D metabolism by understanding the
biology of vitamin D and the CYP27B1 enzyme activity at
tissue-specific levels.
Quantitative MSI Feasibility. A VitD metabolite-stable
isotope (deuterium labeled, d2) was used in this study as an
ISTD for method development purposes, and it is currently
commercially available. Therefore, quantitative MSI (qMSI) of
VitD metabolites would be achievable by applying well-known
models such as mimetic tissue, tissue extinction coefficient, and
standard on-tissue spotting. Because VitD metabolites are
endogenously present in key metabolic tissues such as kidney,
a potential qMSI approach is to use a calibration based on a
range of known deuterated labeled VitD solutions (used as
standards) with a fixed amount of a 13C labeled (as an ISTD)
spiked onto a series of tissue homogenates. As the ionization is
mainly driven by the derivatization reagent quaternary amine
moiety, it would be valid to assume that the response factors of
all Amplifex-VitD derivatives will be close to 1. In this case, the
more conservative and accurate qMSI approach would be to
use the mimetic tissue method as it would minimize any
topology-related effects, usually observed during manual or
automated tissue-spotting approaches. Analysis could be
performed using VitD (d2/
13C) ratios containing pixels
employing three replicates and two MSI platforms such as
MALDI-TOF-qMSI and MALDI−FTICR-qMSI. The average
intensity of each layer of the mimetic tissue model can be
correlated with the known spiked concentration to generate a
calibration curve. This curve can then be used to quantify ROIs
on the target tissue. These results will be compared to the
conventional gold standard quantitative platform using
HPLC−MS/MS. For calculations, linear or nonlinear
regression analysis can be used depending on factors such as
matrix-to-analyte ratio, nonuniform tissue-ion suppression,
interferences from matrix background signals, and different
ion detection/counting technologies.
■ CONCLUSIONS
MSI with OTCD is a powerful new tool to study the spatial
distribution of vitamin D metabolites within tissues. This is the
first technique capable of detecting and potentially quantifying
low physiological endogenous tissue levels of vitamin D
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metabolites. qMSI using stable isotope standards would be
achieved by applying well-established qMSI approaches. We
have demonstrated its utility for measuring endogenous
concentrations within murine kidney, a key metabolic organ
for vitamin D metabolism. This offers the opportunity for
many novel insights into tissue-specific vitamin D biology.
Moreover, the suitability of using the automated ImagePrep for
reagent deposition and as a reaction chamber for OTCD-based
platforms shows a promising outcome and offers the ideal
conditions to achieve reproducible MSI images. Importantly,
the use of OTCD−MSI facilitates/enables the analysis of
previously inaccessible biologically relevant molecules through
adaptation of existing CD methods.
■ MATERIALS AND METHODS
Sources of Chemicals. ISTD 26,26,26,27,27,27-D6-25-
hydroxyvitamin D3 (d6-25-(OH)-D3), Amplifex Diene reagent,
4-phenyl-1,2,4-trazoline-3,5-dione (PTAD), and α-cyano-4-
hydroxycinnamic acid (CHCA) were obtained from Sigma-
Aldrich (UK). 1α,25-Dihydroxyvitamin D3 (1,25-(OH)2-D3)
was obtained from Enzo Life Sciences (UK). 4-(2-(6,7-
Dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalinyl)ethyl)-
1,2,4-triazoline-3,5-dione reagent (DMEQ-TAD) was pur-
chased from Abcam (UK). Solvents were of HPLC grade
from Fisher Scientific (UK).
Animal and Tissue Collection. Experiments were
conducted in accordance with the Animal (Scientific
Procedures) Act 1986. Male nude CD-1 mice (aged 6−8
weeks, weighing approximately 27−34 g) were housed at a RT
of 20−24 °C, with a 12 h light/dark cycle. Animals were
housed in individually ventilated cages with standard certified
diet food and water provided ad libitum. Animals were
sacrificed by schedule I. Organs were then extracted and snap-
frozen in liquid nitrogen and stored at −80 °C until MSI
analysis.
Tissue Sectioning and Mounting. Tissues were cryosec-
tioned on a sagittal plane for brain tissue (control tissue for
spotting experiments) and top-down (horizontal) section for
mouse kidney (12 μm). Sectioning was performed using a
Leica cryostat model CM 1850 UV (Leica Biosystems,
Nußloch, Germany). Sections were thaw-mounted onto
conductive indium tin oxide-coated slides (Bruker Daltonics,
Bremen, GmbH), dried in a vacuum desiccator (RT, 30 min),
and then stored at −80 °C.
Off- and On-Tissue Method Development and
Amplifex Reaction Condition Optimization. See the
Supporting Information.
OTCD−MSI Analysis of Endogenous Vitamin D
Metabolite Derivatives in Mouse Kidney Tissue
Sections. At −80 °C, tissue sections were dried in a vacuum
desiccator (20 min). Amplifex reagent (5 mL, 0.1 mg/mL in
50:50 v/v acetonitrile/water) was applied to the tissue sections
by ImagePrep (Bruker Daltonics, Bremen, GmbH). The
ImagePrep parameters were set as follows: “matrix thickness”:
40 cycles, spray power: 25%, and a fixed spray time of 2.2 s.
Incubation was set to 30 s with a fixed dry time of 60 s, leading
to a final OTCD time of 60 min/slide with a reagent density of
0.02 mg/cm2. An artistic airbrush was also evaluated as an
OTCD method adapted from Cobice et al.24 Briefly, a reaction
solution of Amplifex (2 mL, 0.25 mg/mL in 50:50 v/v
acetonitrile/water) was sprayed positioned 20 cm away from
the target with a N2 pressure of 1.2 bar. The reagent density
was 0.02 mg/cm2. Then, the slide was placed in a closed
reaction container, containing a 1:1 v/v solution of
acetonitrile/water and a moist Kimwipe under the lid and
placed in an oven at 37 °C for 1 h.
Matrix Application. CHCA (6 mL, 5 mg/mL in 70:30 v/v
acetonitrile/water + 0.1% v/v TFA) was applied in four passes
using a 3D printer, as described in Tucker et al.25 A flow rate of
0.1 mL/min with a gas pressure of 2 bar, a bed temperature of
30 °C, a z-height of 30 mm, and a velocity of 1100 mm/min
were achieved, averaging a run time of 24 min per slide. A
uniform coating of matrix was achieved with 0.12 mg/cm2.
Instrumentation. Spotting assessment and MSI were
performed using a 9.4 T SolariX MALDI−FTICR−MS
(Bruker Daltonik GmbH, Bremen, Germany) employing a
Smartbeam 2 kHz laser, with instrument control using FTMS
control v2.2.0 (build 150) FlexImaging version 5.1 (build 80)
and data analysis using mMass software v5.5.0 for mass spectral
postprocessing and recalibration.26,27 DESI−MSI experiments
were performed on a commercial DESI 2D source (OmniSpray
2D Source, Prosolia Inc, Indianapolis, IN, USA) mounted on a
Waters Xevo G2-XS quadrupole time of flight mass
spectrometer (Waters Corporation, Manchester, UK). CD
reaction optimization was performed on an Applied Bio-
systems/MDS Sciex 4800 MALDI TOF/TOF mass spec-
trometer (Foster City, California, USA) equipped with a
neodymium-doped yttrium aluminum garnet (Nd:YAG) laser
operating at 355 nm (200 Hz repetition rate). The mass range
was acquired from 400 to 800 Da, focusing on the appropriate
base peak ion in positive reflector mode. The instrument was
calibrated using CAL MIX 5 as per manufacturer guidelines.
Confirmatory LC−MS/MS analysis was performed using a
triple-quadrupole linear ion trap mass spectrometer (QTRAP
6500, AB Sciex, Cheshire, UK) coupled with an ACQUITY
ultra-high-pressure liquid chromatography system (UHPLC;
Waters, Manchester, UK).
MALDI−FTICR−MSI. MALDI−MSI was performed using a
9.4 T SolariX. The instrument was calibrated prior to analysis
using red phosphorus clusters during method development and
optimization operated in magnitude mode at 516 K size at a
mass range of m/z 600−900 using one average scan in positive
ion mode. Four hundred shots were accumulated per pixel/
spot at 2000 Hz frequency employing a minimum laser focus.
Kidney section images were acquired using the optimized
imaging method operated in constant accumulation of selected
ion mode at m/z 732 (Q-isolation) with an isolation window
of 100 Da in positive ion mode. The mass resolution at m/z
700 was 40,000. The same laser parameters were used as per
the development method. Images were acquired at a spatial
resolution of 100 × 100 μm, generated using the FlexImaging
version 5.1 software (Bruker Daltonik GmbH), and then
normalized with the total ion current (TIC). A 95% data
reduced profile spectrum and spectrum peak list were saved for
further analysis. Optical images were taken using a flatbed
scanner (Cannon LiDE-20, Cannon, UK). CID experiment on
1,25-(OH)2-D3 was performed at m/z 748.49 with an isolation
window of 20 Da, isolation time of 2 s, and 800 laser shots
using 35 eV collision energy.
DESI−MSI. See the Supporting Information.
Confirmatory LC−MS/MS Analysis. See the Supporting
Information.
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(27) Slad́kova,́ K.; Housǩa, J.; Havel, J. Laser desorption ionization
of red phosphorus clusters and their use for mass calibration in time-
of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23,
3114−3118.
(28) Bikle, D. D.; Patzek, S.; Wang, Y. Physiologic and
pathophysiologic roles of extra renal CYP27b1: Case report and
review. BoneKEy Rep. 2018, 8, 255−267.
(29) Feldman, D.; Krishnan, A. V.; Swami, S.; Giovannucci, E.;
Feldman, B. J. The role of vitamin D in reducing cancer risk and
progression. Nat. Rev. Canc. 2014, 14, 342−357.
(30) Maguire, O.; Pollock, C.; Martin, P.; Owen, A.; Smyth, T.;
Doherty, D.; Campbell, M. J.; McClean, S.; Thompson, P. Regulation
of CYP3A4 and CYP3A5 expression and modulation of “intracrine”
metabolism of androgens in prostate cells by liganded vitamin D
receptor. Mol. Cell. Endocrinol. 2012, 364, 54−64.
(31) Jensen, M. B.; Andersen, C. B.; Nielsen, J. E.; Bagi, P.;
Jørgensen, A.; Juul, A.; Leffers, H. Expression of the vitamin D
receptor, 25-hydroxylases, 1α-hydroxylase and 24-hydroxylase in the
human kidney and renal clear cell cancer. J. Steroid Biochem. Mol. Biol.
2010, 121, 376−382.
ACS Omega http://pubs.acs.org/journal/acsodf Article
https://dx.doi.org/10.1021/acsomega.0c01697
ACS Omega XXXX, XXX, XXX−XXX
H
